Combined Vaginal Misoprostol and Perivascular Vasopressin
Status:
Recruiting
Trial end date:
2019-12-31
Target enrollment:
Participant gender:
Summary
Injection of Vasopressin into the uterine tissue surrounding fibroids constricts blood
vessels, and has been found to be beneficial by decreasing blood flow to fibroids, and
thereby resulting in less bleeding with removal. Additionally, Misoprostol has been looked at
as an additional method to decrease operative blood loss given its ability to increase
uterine muscle tone, which therefore constricts the amount of blood flow to the uterus.